Chronic stable angina: Addressing the needs of patients through risk reduction, education and support

Berra, Kathy; Fletcher, Barbara J.; Miller, Nancy Houston

doi:10.25011/cim.v31i6.4927

Cited by 4 publications

(3 citation statements)

References 16 publications

(21 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In this analysis, the performance of the EQ-5D and SF-6D was evaluated against the five dimensional scales of the SAQ as an external indicator of health status. Scores for each scale were divided into two groups (>= 50 and<50) indicating better cardiac functioning and worse functioning [ 38 ]. ES was used to define the discriminative capacity, and was computed as the difference between the mean of the two groups mentioned above, divided by the pooled standard deviation.…”

Section: Methodsmentioning

confidence: 99%

Validation and comparison of EuroQoL-5 dimension (EQ-5D) and Short Form-6 dimension (SF-6D) among stable angina patients

Han

Zhao

et al. 2014

Health Qual Life Outcomes

View full text Add to dashboard Cite

ObjectivesSeveral preference-based health-related quality of life (HRQoL) instruments have been published and widely used in different populations. However no consensus has emerged regarding the most appropriate instrument in therapeutic area of stable angina. This study compared and validated the psychometric properties of two generic preference-based instruments, the EQ-5D and SF-6D, among Chinese stable angina patients.MethodsConvergent validity of the EQ-5D and SF-6D was examined with eight a priori hypotheses from stable angina patients in conjunction with Seattle Angina Questionnaire (SAQ). Responsiveness was compared using the effect size (ES), relative efficiency (RE) and receiver operating characteristic (ROC) curves. Agreement between the EQ-5D and SF-6D was tested using intra-class correlation coefficient (ICC) and Bland-Altman plot. Factors affecting utility difference were explored with multiple linear regression analysis.ResultsIn 411 patients (mean age 68.08 ± 11.35), mean utility scores (SD) were 0.78 (0.15) for the EQ-5D and 0.68 (0.12) for the SF-6D. Validity was demonstrated by the moderate to strong correlation coefficients (Range: 0.368-0.594, P< 0.001) for five of the eight hypotheses in both the EQ-5D and SF-6D. There were no serious floor effects for the EQ-5D and SF-6D, but ceiling effects for the EQ-5D were large. The areas under ROC of them all exceeded 0.5 (0.660-0.814, P< 0.001). The SF-6D showed a better discriminative capacity (ES: 0.573 to 1.179) between groups with different stable-angina-specific health status than the EQ-5D (ES: 0.426 to 1.126). RE suggested that the SF-6D (RE: 44.8 to 177.8%) was more efficient than the EQ-5D except for physical function. Poor agreement between them was observed with ICC (0.448, P< 0.001) and Bland-Altman plot analysis. Multiple liner regression showed that clinical variables significantly (P< 0.05) influenced differences in utility scores between the EQ-5D and SF-6D.ConclusionsBoth EQ-5D and SF-6D are valid and sensitive preference-based HRQoL instruments in Chinese stable angina patients. The SF-6D may be a more effective tool with lower ceiling effect and greater sensitivity. Further study is needed to compare other properties, such as reliability and longitudinal response.

show abstract

Section: Methodsmentioning

confidence: 99%

Validation and comparison of EuroQoL-5 dimension (EQ-5D) and Short Form-6 dimension (SF-6D) among stable angina patients

Han

Zhao

et al. 2014

Health Qual Life Outcomes

View full text Add to dashboard Cite

show abstract

“…A medical evaluation including an exercise stress test is generally indicated for patients with angina prior to a regular physical activity program. 17 The goals of pharmacological treatment include: (1) alleviation of symptoms, extending exercise duration, and improvement in QoL, (2) improvement in prognosis and prevention of CV events by reducing acute coronary thrombosis incidence and slowing atherosclerotic progression and ventricular dysfunction. 18 Ferrari et al have described guideline-recommended drug therapies for the alleviation of chronic stable angina.…”

Section: Angina Risk Factor Reductionmentioning

confidence: 99%

Consensus statement on cardiovascular risk stratification and aggressive management of chronic coronary syndromes

et al. 2023

View full text Add to dashboard Cite

Cardiovascular diseases (CVDs) are responsible for 17.5 million deaths globally, and India is more susceptible to coronary artery disease (CAD) than its western counterparts because of certain challenges such as suboptimal management, increased healthcare costs, and physicians undermining the extent of limitation in angina patients. All of these could be resolved by employing strategies starting with accurate diagnosis to timely implementation of aggressive management techniques to contain morbidity and mortality. Pan India, experts from the field of cardiology came together in order to discuss risk stratification and aggressive management of chronic coronary syndromes (CCS). The expert consensus laid down a path of recommendations considering the prevailing healthcare service infrastructure, local evidence-based studies and key international guidelines. With the wide diversity in terms of geographical distribution in India and the risk factors presented across various divisions of the population, risk stratification is necessary for prompt identification and subsequent management of CCS. In this consensus, various risk stratification techniques such as risk stratification based on ventricular function, electrocardiogram (ECG), stress echocardiography (ECHO), the Duke treadmill score (DTS), and myocardial perfusion imaging (MPI) were discussed. After risk stratification, the consensus focused on aggressive management of CVDs with therapeutic optimization for various types of patient profiles such as revascularization for stable angina and angina with comorbidities (diabetes and renal failure), apart from emphasis on various medications and their roles in ameliorating disease symptoms.

show abstract

“…Although chest pain or discomfort is the primary and perhaps most specific symptom experienced by people with chronic stable angina, it often occurs with other symptoms, in particular fatigue and dyspnoea (Hagman & Wilhelmsen 1981, Berra et al. 2008, Herlitz et al.…”

Section: Introductionmentioning

confidence: 99%

Symptom clusters and health-related quality of life in people with chronic stable angina

Kimble

Dunbar

Weintraub

et al. 2011

Journal of Advanced Nursing

View full text Add to dashboard Cite

Aim-This paper reports findings of a study to examine the independent contribution of chest pain, fatigue, and dyspnea to health-related quality of life in patients with chronic stable angina.Background-Patients with chronic stable angina experience poorer quality of life in multiple areas including physical and emotional health. Emerging evidence suggests the presence of concomitant symptoms, yet there are no systematic studies examining the impact of symptom clusters on quality of life in chronic angina patients.

show abstract

Chronic stable angina: Addressing the needs of patients through risk reduction, education and support

Cited by 4 publications

References 16 publications

Validation and comparison of EuroQoL-5 dimension (EQ-5D) and Short Form-6 dimension (SF-6D) among stable angina patients

Validation and comparison of EuroQoL-5 dimension (EQ-5D) and Short Form-6 dimension (SF-6D) among stable angina patients

Consensus statement on cardiovascular risk stratification and aggressive management of chronic coronary syndromes

Symptom clusters and health-related quality of life in people with chronic stable angina

Contact Info

Product

Resources

About